Drug investment PPT

Name of drug

Approved for

Effectiveness

Cost per month

Sadkyla

· All patients with beginning stages of breast cancer

· Prevents tumor growth in 50% of patients for two years

· 50% of patients see no effect from drug

· $3,000/month

Herjetta

· Effective for 80% of patients with early to moderate stage cancer

· Increases median life span by 4 months

· $5,000/month

Himceptrin

· Patients with the most serious forms of breast cancer

· Increases median life span by 6 months

· $10,000/month

Comanapracil

· All patients

· Prevents tumor growth in 100% of patients for two years

· ??